Table 1.
ID number | Age at baseline | Sex M/F | BCG scar (Y/N) | TST at baseline (mm) | IFN-γ responses at baseline (Jan/Feb 2004) | IFN-γ responses at second survey, 4 months after INH treatment (Jan 2005) | IFN-γ responses at third survey, 10 months after INH treatment (July 2005) | |||
Result (Pos/Neg)* | IU/mL** | Result (Pos/Neg)* | IU/mL** | Result (Pos/Neg)* | IU/mL** | |||||
10055 | 19 | F | Y | 14 | P | 10.0 | P | 10.0 | P | 10.0 |
10066 | 19 | F | Y | 15 | P | 10.0 | P | 2.55 | P | 10.0 |
10069 | 19 | F | Y | 17 | P | 9.55 | P | 10.0 | P | 10.0 |
10077 | 19 | F | N | 19 | P | 10.0 | P | 4.34 | P | 2.04 |
10082 | 19 | F | Y | 18 | P | 10.0 | P | 10.0 | P | 5.86 |
10089 | 19 | F | Y | 16 | P | 10.0 | P | 8.35 | P | 1.51 |
10093 | 19 | F | N | 20 | P | 10.0 | P | 5.13 | P | 3.31 |
10115 | 24 | F | Y | 17 | P | 0.39 | N | 0 | N | 0.21 |
10282 | 19 | F | N | 15 | P | 1.21 | P | 4.40 | P | 10.0 |
10290 | 18 | F | N | 18 | P | 10.0 | P | 4.81 | P | 10.0 |
Mean (SD) | 8.1 (3.9) | 5.9 (3.5) | 6.3 (4.2) | |||||||
Median | 10.0 | 5.0 | 7.9 |
*QFT-G cut-point for positivity: ≥0.35 IU/mL
** IFN-γ values >10.0 IU/mL have been shown as 10 IU/mL
TST: tuberculin skin test; QFT-G: QuantiFERON-TB Gold In Tube assay; INH: isoniazid; BCG: bacille Calmette-Guerin; SD: standard deviation